IL5 and myeloid sarcoma: In P-MS patients, a significant difference was found only for IL-5 CSF levels (T-allele, median [IQR] = 0.1 [0–0.23] vs. C-allele, median [IQR] = 0.6 [0.0–2.5]; p = 0.022) (Figure 3B).